Literature DB >> 26254179

Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview.

Alfredo R Galassi1, Emmanouil S Brilakis2, Marouane Boukhris3, Salvatore D Tomasello4, Georgios Sianos5, Dimitri Karmpaliotis6, Carlo Di Mario7, Bradley H Strauss8, Stephane Rinfret9, Masahisa Yamane10, Osamu Katoh11, Gerald S Werner12, Nicolaus Reifart13.   

Abstract

Coronary chronic total occlusions (CTOs) are commonly encountered in patients undergoing coronary angiography. Several observational studies have demonstrated that successful CTO revascularization is associated with better cardiovascular outcomes and enhanced quality of life (QOL). However, in the absence of randomized trials, its prognostic benefit for patients remains debated. Over the past decade, the interest of the interventional community in CTO percutaneous coronary intervention (PCI) has exponentially grown due to important developments in dedicated equipment and techniques, resulting in high success and low complication rates. Both European and American guidelines have assigned a class IIa (level of evidence B) recommendation for CTO PCI. In the current review, we focus on the impact of CTO revascularization on clinical outcomes and QOL and on appropriate patient selection, and we provide a critical assessment of the current guidelines and recommendations on CTO PCI. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular outcome; Chronic total occlusion; Guidelines; PCI; Quality of life

Mesh:

Year:  2015        PMID: 26254179     DOI: 10.1093/eurheartj/ehv391

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  Meta-analyses and randomized trials investigating percutaneous coronary intervention of chronic total occlusions: what is left to explore?

Authors:  Bimmer E Claessen; Loes P Hoebers; Joelle E Elias; Ivo M van Dongen; José P S Henriques
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

3.  Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?

Authors:  Marouane Boukhris; Kambis Mashayekhi; Zied Ibn Elhadj; Alfredo R Galassi
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 4.  [Chronic coronary occlusions : When and how should revascularization be performed?]

Authors:  K Mashayekhi; H J Büttner
Journal:  Herz       Date:  2016-11       Impact factor: 1.443

5.  Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.

Authors:  Li Wang; Min-Jie Lu; Lei Feng; Juan Wang; Wei Fang; Zuo-Xiang He; Ke-Fei Dou; Shi-Hua Zhao; Min-Fu Yang
Journal:  J Nucl Cardiol       Date:  2018-03-07       Impact factor: 5.952

6.  Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

Authors:  Yevgeniy Khariton; Sophia Airhart; Adam C Salisbury; John A Spertus; Kensey L Gosch; J Aaron Grantham; Dimitrios Karmpaliotis; Jeffrey W Moses; William J Nicholson; David J Cohen; William Lombardi; James Sapontis; James M McCabe
Journal:  JACC Cardiovasc Interv       Date:  2018-11-26       Impact factor: 11.195

7.  Surgical decision making for revascularization of chronically occluded right coronary artery.

Authors:  Andreas Borowski; Erhard Godehardt; Hannan Dalyanoglu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-08-08

8.  Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis.

Authors:  Alberto Polimeni; Remzi Anadol; Thomas Münzel; Martin Geyer; Salvatore De Rosa; Ciro Indolfi; Tommaso Gori
Journal:  BMC Cardiovasc Disord       Date:  2019-03-15       Impact factor: 2.298

9.  Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience.

Authors:  Erdem Özel; Ahmet Taştan; Ali Öztürk; Emin Evren Özcan; Baris Kilicaslan; Öner Özdogan
Journal:  Cardiovasc J Afr       Date:  2016-04-12       Impact factor: 1.167

10.  Chronic refractory angina pectoris: recent progress and remaining challenges.

Authors:  Johannes Waltenberger
Journal:  Eur Heart J       Date:  2017-09-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.